Skip to main content
Article
Survival After Failure of Initial Therapy for Newly-Diagnosed or Relapsed/Refractory AML At An Academic Center: Subsequent Clinical Trial Vs. Not
Blood (2011)
  • Ravinder K Sandhu, Fred Hutchinson Cancer Research Center
  • Jack M. Lionberger, Fred Hutchinson Cancer Research Center
  • Megan Othus, Fred Hutchinson Cancer Research Center
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Kathleen ShannonDorcy, Fred Hutchinson Cancer Research Center
  • Paul C. Hendrie, University of Washington
  • Stephen H. Petersdorf, Fred Hutchinson Cancer Research Center
  • Pamela S Becker, University of Washington
  • Frederick R. Appelbaum, Fred Hutchinson Cancer Research Center
  • Elihu H Estey, Fred Hutchinson Cancer Research Center
Publication Date
November 18, 2011
Citation Information
Ravinder K Sandhu, Jack M. Lionberger, Megan Othus, John M. Pagel, et al.. "Survival After Failure of Initial Therapy for Newly-Diagnosed or Relapsed/Refractory AML At An Academic Center: Subsequent Clinical Trial Vs. Not" Blood Vol. 118 Iss. 21 (2011) p. 1497 - 1497
Available at: http://works.bepress.com/john-pagel/172/